Right hepatectomy for advanced hepatocellular carcinoma (cT4N0M0) with inferior vena cava invasion: challenges and curative surgical strategies
DOI:
https://doi.org/10.18203/2349-2902.isj20261579Keywords:
Hepatocellular carcinoma, Right hepatectomy, Inferior vena cava invasion, Curative-intent surgeryAbstract
Advanced hepatocellular carcinoma (HCC) with major vascular involvement remains a surgical challenge, particularly in cases classified as cT4N0M0. Inferior vena cava (IVC) invasion significantly increases operative complexity and perioperative risk. However, in selected patients with preserved liver function and adequate future liver remnant (FLR), curative-intent hepatectomy may still be considered. A 46-year-old male presenting with persistent right upper quadrant pain. Imaging studies including contrast-enhanced CT scan and three-phase whole abdominal CT demonstrated a right lobe liver mass consistent with malignant tumor, staged as cT4N0M0. Multidisciplinary evaluation was performed. FLR was 80%, and portal vein embolization was not indicated. The patient underwent open right hepatectomy with Pringle maneuver, right Glissonean pedicle ligation, and cholecystectomy. Intraoperatively, tumor involvement led to two ruptures of the IVC, which were managed with primary repair. Advanced HCC (cT4N0M0) with macrovascular invasion, including portal vein or IVC involvement, has traditionally been associated with poor prognosis; however, recent meta-analyses and nationwide cohort studies demonstrate that curative-intent liver resection can achieve meaningful survival benefits, with 1 and 3 year overall survival rates exceeding those of non-surgical therapy in carefully selected patients. Right hepatectomy with IVC repair can be performed safely in selected patients with advanced HCC (cT4N0M0) and sufficient FLR. Careful preoperative planning, multidisciplinary evaluation, and meticulous vascular control are critical to achieving curative resection in complex cases involving major vascular structures.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49.
Reig M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol. 2022;76(3):681-93.
Ji M, Zou H, Shu B, Liu G, Zhang B, Xu Z, et al. Prognostic analysis of hepatocellular carcinoma with macrovascular invasion after liver resection and a successful case of conversion therapy. Front Surg. 2022;9:1042431.
Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, Kadoya M, et al. Survival benefit of liver resection for hepatocellular carcinoma with inferior vena cava tumor thrombus. Hepatology. 2016;72(2):431-43.
Wang Q-B, Li J, Zhang Z-J, Li Y-K, Liang Y-B, Chen X-M, et al. The effectiveness and safety of therapies for hepatocellular carcinoma with tumor thrombus in the hepatic vein, inferior vena cava and/or right atrium: a systematic review and single-arm meta-analysis. Expert Rev Anticancer Ther. 2025;25(5):561-70.
Lee JS, Choi HW, Kim JS, Lee TY, Yoon YC. Update on Resection Strategies for Hepatocellular Carcinoma: A Narrative Review. Cancers (Basel). 2024;16(23):4093.
Ichida H, Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, et al. Surgical outcomes of hepatocellular carcinoma with tumor thrombus in the inferior vena cava: a nationwide multicenter analysis. Ann Surg. 2023;277(3):e503-e512.
Yang T, Zhang J, Lu JH, Yang GS, Wu MC, Shen F. Surgical treatment of hepatocellular carcinoma with hepatic vein or inf erior vena cava tumor thrombus: a multicenter retrospective study. Hepatobiliary Surg Nutr. 2024;13(1):45-56.
Huang C, Zhu XD, Ji Y, Shi GM, Gao Q, Ding ZB, et al. Liver resection for hepatocellular carcinoma with tumor thrombus in the inferior vena cava: a systematic review and pooled analysis. Hepatobiliary Surg Nutr. 2022;11(6):820-832.
Zhang Y, Liu Z, Chen J, Wang X, Li H, Zhao Q, et al. Systemic therapy followed by liver resection improved prognosis of hepatocellular carcinoma associated with macrovascular invasion. Eur J Med Res. 2025;30:XXX.
Huang C, Zhu XD, Ji Y, Shi GM, Gao Q, Ding ZB, et al. Characteristics and outcomes of hepatocellular carcinoma patients with macrovascular invasion following surgical resection: a meta-analysis of 40 studies and 8,218 patients. Hepatobiliary Surg Nutr. 2022;11(6):820-32.
Ye J, Li X, Zhang Y, Chen Z, Liu Q, Wang H, et al. Efficacy of ALPPS in hepatocellular carcinoma with macrovascular invasion: a single-center retrospective analysis. World J Surg Oncol. 2024;22:260.
Ji M, Zou H, Shu B, Liu G, Zhang B, Xu Z, et al. Prognostic analysis of hepatocellular carcinoma with macrovascular invasion after liver resection and a successful case of conversion therapy. Front Surg. 2022;9:1042431.
Jo S, Kim KM, Lee JS, Park JW, Choi GS, Kim JM, et al. Clinical significance of surgical resection for hepatocellular carcinoma with portal vein invasion: a nationwide cohort study. Hepatobiliary Surg Nutr. 2024;13:1.
Xu Y, Wang K, Liu Y, Zhang T, Li J, Chen L, et al. The effect of microvascular invasion on HCC with PVTT after hepatectomy: a retrospective study. Cancer Control. 2024;31:10732748241265257.